HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

PCSK9 inhibitors lower circulating cholesterol only, not brain cholesterol

Louis Nervegna · Mar 09, 2025 · ♥ 16 reactions · 24 comments · original Facebook post
PCSK9, ezetimibe & newer drugsBrain health & dementiaLDL, ApoB & lipid panel
AI summary & key facts

Louis states that PCSK9 inhibitors lower cholesterol only in circulation and not in the brain, because circulating cholesterol cannot cross the blood-brain barrier and the brain produces its own. He frames this as basic physiology countering claims about brain harm from lower LDL.

PCSK9 inhibitors do NOT lower cholesterol in the brain.

These drugs only lower cholesterol in circulation. Your brain makes all of its own cholesterol internally. The cholesterol in circulation can NOT cross the blood barrier. Circulating cholesterol has no effect on the cholesterol levels in your brain. This is basic physiology. Ask your cardiologist.

#bbbHD #braincholesterolHD #dementiaHD #alzheimersHD #pcsk9HD #brainHD #pcsk9dementiaHD #dayspringHD #ldldementiaHD #lowldlHD

No photo description available.
← newer: Circulating LDL can't cross the blood-brain barrier; LDL is older: Rapid heartbeat is most often AFib, but coronary blockage is →